The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanisms.
1. Intravenous bolus doses of thyrotrophin releasing hormone (TRH, 50-1000 micrograms) caused statistically significant, non-dose dependent and transient rises in blood pressure, heart rate and plasma catecholamines in healthy young males. 2. Mean peak incremental rises in systolic blood pressure (m...
Main Authors: | Bouloux, P, Corsello, S, Besser, M, Grossman, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1996
|
Similar Items
-
Pyridostigmine, an Acetylcholinesterase Inhibitor, Stimulates Growth Hormone Release, but has no Effect on Basal Thyrotrophin or Adrenocorticotrophin Levels, or the Thyrotrophin Response to Thyrotrophin-Releasing Hormone.
by: Freeman, E, et al.
Published: (1990) -
Spontaneous growth hormone (GH) pulsatility is the major determinant of GH release after thyrotrophin-releasing hormone in adolescent diabetics.
by: Edge, J, et al.
Published: (1989) -
Thyrotropin-Releasing Hormone (TRH) : An Alternative Therapy for Infantile Spasms
by: J Gordon Millichap
Published: (1987-06-01) -
Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone.
by: Delitala, G, et al.
Published: (1989) -
Thyrotropin releasing hormone (TRH) in the brainstem: Role of Pavlov’s vagally mediated cephalic phase of gastric secretion
by: Yvette Taché
Published: (2020-09-01)